| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3261785 | Digestive and Liver Disease | 2015 | 6 Pages |
BackgroundShorter infusions of infliximab for inflammatory bowel disease seem to be as tolerated as standard procedures and nurses may be able to manage them safely.AimsTo test tolerability and effectiveness of a fast nurse-led infusion procedure and the related patients’ satisfaction.MethodsWe retrospectively compared three different regimens adopted in our outpatient infusion unit from 2010 to 2013: Group 1, a standard procedure with two-hour infusions, preceded by hydrocortisone medication (87 patients, 311 infusions); Group 2, a similar regimen without physician supervision (130 patients, 464 infusions); Group 3, a one-hour nurse-led procedure without routine premedication (176 patients, 1356 infusions). Disease characteristics, infusion reactions, infusions per month and patients’ satisfaction were recorded.ResultsThere were significantly fewer infusion reactions in Group 3 than Group 1 (2.2% versus 5.8% respectively; p = 0.001). The only significant risk factor for side effects was premedication (odds ratio 4.71, 95% confidence interval 2.21–10.02, p < 0.001) which was related to the presence of previous side effects. Number of infusions per month increased by 27% (83 versus 61, p < 0.001) without increasing nurses’ workload and patients were satisfied.ConclusionsOur fast nurse-led procedure was well tolerated, effective and satisfactory for patients.
